Tower Research Capital LLC (Trc) Prelude Therapeutics Inc Transaction History
Tower Research Capital LLC (Trc)
- $3.39 Billion
- Q3 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Prelude Therapeutics Inc stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 6,927 shares of PRLD stock, worth $10,598. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,927
Previous 16,799
58.77%
Holding current value
$10,598
Previous $13,000
30.77%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding PRLD
# of Institutions
47Shares Held
28MCall Options Held
0Put Options Held
0-
Orbimed Advisors LLC San Diego, CA10.9MShares$16.7 Million0.5% of portfolio
-
Baker Bros. Advisors LP New York, NY10.1MShares$15.5 Million0.11% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.15MShares$1.75 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.07MShares$1.64 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA993KShares$1.52 Million0.0% of portfolio
About Prelude Therapeutics Inc
- Ticker PRLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,369,200
- Market Cap $55.6M
- Description
- Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT543 that is in Phase 1 clinical trials in select solid tumors and myeloid malignancies; and PRT811, which is in Phase 1 clinical trials in solid ...